Furthermore, DNA methylation profiling based on the NGS analysis of 156 patients indicated that the methylation difference in matched normal‐tumor pairs was located in regions −200 to −500 and −1000 to −1400 bp on the CEACAM5 promoter (Figure 4A,B). The gene discussed is CEACAM5; the disease is neoplasm.